M.Th.M. Tulp

1.9k total citations
55 papers, 1.5k citations indexed

About

M.Th.M. Tulp is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, M.Th.M. Tulp has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Organic Chemistry and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in M.Th.M. Tulp's work include Neurotransmitter Receptor Influence on Behavior (15 papers), Receptor Mechanisms and Signaling (13 papers) and Synthesis and Biological Evaluation (9 papers). M.Th.M. Tulp is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (15 papers), Receptor Mechanisms and Signaling (13 papers) and Synthesis and Biological Evaluation (9 papers). M.Th.M. Tulp collaborates with scholars based in Netherlands, Belgium and Canada. M.Th.M. Tulp's co-authors include I. van Wijngaarden, W. Soudijn, O. Hutzinger, Chris G. Kruse, Berend Olivier, J. Schipper, J. Mos, Wout Wouters, Göran Sundström and J.A.M. van der Heyden and has published in prestigious journals such as Chemosphere, Journal of Medicinal Chemistry and Journal of Chromatography A.

In The Last Decade

M.Th.M. Tulp

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.Th.M. Tulp Netherlands 22 602 575 331 220 133 55 1.5k
F. Cattabeni Italy 25 974 1.6× 464 0.8× 125 0.4× 101 0.5× 168 1.3× 107 1.9k
William B. Stavinoha United States 23 621 1.0× 510 0.9× 144 0.4× 92 0.4× 207 1.6× 62 1.7k
Andrew Holt Canada 25 952 1.6× 270 0.5× 162 0.5× 158 0.7× 224 1.7× 70 2.2k
H. Schoemaker Netherlands 33 1.2k 2.0× 1.0k 1.8× 644 1.9× 75 0.3× 214 1.6× 96 3.3k
Darlene C. Deecher United States 25 636 1.1× 528 0.9× 224 0.7× 35 0.2× 117 0.9× 55 2.1k
Silvana A. Andrić Serbia 30 548 0.9× 165 0.3× 258 0.8× 183 0.8× 309 2.3× 86 2.1k
Domènec J. Sánchez Spain 32 833 1.4× 922 1.6× 128 0.4× 747 3.4× 232 1.7× 76 3.0k
Eddie Wei United States 21 678 1.1× 991 1.7× 72 0.2× 437 2.0× 429 3.2× 39 2.1k
Edith Heilbronn Sweden 24 852 1.4× 609 1.1× 148 0.4× 273 1.2× 95 0.7× 107 2.0k
Mark W. Dudley United States 21 524 0.9× 365 0.6× 362 1.1× 59 0.3× 57 0.4× 38 1.3k

Countries citing papers authored by M.Th.M. Tulp

Since Specialization
Citations

This map shows the geographic impact of M.Th.M. Tulp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.Th.M. Tulp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.Th.M. Tulp more than expected).

Fields of papers citing papers by M.Th.M. Tulp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.Th.M. Tulp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.Th.M. Tulp. The network helps show where M.Th.M. Tulp may publish in the future.

Co-authorship network of co-authors of M.Th.M. Tulp

This figure shows the co-authorship network connecting the top 25 collaborators of M.Th.M. Tulp. A scholar is included among the top collaborators of M.Th.M. Tulp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.Th.M. Tulp. M.Th.M. Tulp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Stephen, et al.. (2001). New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D2-receptor and serotonin 5-HT1A-receptor affinities. Bioorganic & Medicinal Chemistry Letters. 11(17). 2345–2349. 32 indexed citations
2.
Homan, Evert, et al.. (1999). C5-Substituted Derivatives of 5-OMe-BPAT: Synthesis and Interactions with Dopamine D2 and Serotonin 5-HT1A Receptors. Bioorganic & Medicinal Chemistry. 7(11). 2541–2548. 4 indexed citations
3.
Seerden, Jean-Paul G., M.Th.M. Tulp, Hans W. Scheeren, & Chris G. Kruse. (1998). Synthesis and structure–Activity data of some new epibatidine analogues. Bioorganic & Medicinal Chemistry. 6(11). 2103–2110. 29 indexed citations
5.
Wijngaarden, I. van, et al.. (1995). A Series of N4-Imidoethyl Derivatives of 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)piperazine as 5-HT1A Receptor Ligands: Synthesis and Structure-Affinity Relationships. Journal of Medicinal Chemistry. 38(21). 4303–4308. 16 indexed citations
6.
Leurs, Rob, et al.. (1995). Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5‐HT3 receptor revealed. British Journal of Pharmacology. 116(4). 2315–2321. 55 indexed citations
7.
Wijngaarden, I. van, et al.. (1995). N4-Unsubstituted N1-Arylpiperazines as High-Affinity 5-HT1A Receptor Ligands. Journal of Medicinal Chemistry. 38(11). 1942–1954. 25 indexed citations
8.
Olivier, Berend, et al.. (1994). Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan. European Journal of Pharmacology. 256(2). 141–147. 16 indexed citations
9.
Wijngaarden, I. van, et al.. (1993). Structure-affinity relationship studies on 5-HT1A receptor ligands. 1. Heterobicyclic phenylpiperazines with N4-alkyl substituents. Journal of Medicinal Chemistry. 36(19). 2751–2760. 36 indexed citations
10.
Olivier, Berend, L. M. C. van den Bosch, Jan Van der Heyden, et al.. (1993). Preclinical Evidence on the Psychotropic Profile of Fluvoxamine. Pharmacopsychiatry. 26(S 1). 2–9. 29 indexed citations
11.
Lucot, James B., K. J. van Charldorp, & M.Th.M. Tulp. (1991). Idaverine, an M2- vs. M3-selective muscarinic antagonist, does not prevent motion sickness in cats. Pharmacology Biochemistry and Behavior. 40(2). 345–349. 8 indexed citations
12.
Schipper, J., et al.. (1990). NEUROCHEMICAL PROFILE OF ELTOPRAZINE. Drug metabolism and drug interactions. 8(1-2). 85–114. 41 indexed citations
13.
Wijngaarden, I. van, Chris G. Kruse, J.A.M. van der Heyden, & M.Th.M. Tulp. (1988). 2-Phenylpyrroles as conformationally restricted benzamide analogs. A new class of potential antipsychotics. 2. Journal of Medicinal Chemistry. 31(10). 1934–1940. 35 indexed citations
14.
Wouters, Wout, et al.. (1988). Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors. European Journal of Pharmacology. 149(3). 213–223. 68 indexed citations
16.
Tulp, M.Th.M., et al.. (1986). Timelotem - an Antipsychotic Benzodiazepine Derivative. Pharmacopsychiatry. 19(4). 218–219. 3 indexed citations
17.
Janszen, F.H.A., et al.. (1985). Differential effects of metoclopramide and zetidoline on gastrointestinal motility. European Journal of Pharmacology. 108(2). 105–112. 3 indexed citations
18.
Tulp, M.Th.M. & O. Hutzinger. (1978). Rat metabolism of polychlorinated dibenzo-p-dioxins. Chemosphere. 7(9). 761–768. 39 indexed citations
19.
Tulp, M.Th.M. & O. Hutzinger. (1977). Use of ethyl ethers, deuteriomethyl ethers and cyclic n-butylboronates of hydroxychlorobiphenyls in identification of metabolites of polychlorinated biphenyls. Journal of Chromatography A. 139(1). 51–59. 6 indexed citations
20.
Tulp, M.Th.M., W. A. Bruggeman, & O. Hutzinger. (1977). Reductive dechlorination of chlorobiphenylols by rats. Cellular and Molecular Life Sciences. 33(9). 1134–1136. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026